[PR Newswire] - SEATTLE, July 3, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that a comprehensive article summarizing preclinical and clinical data for pacritinib, an oral ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment